Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

NCT03719768 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT03719768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03719768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Phase 1
Overall status
Completed
Start date
June 10, 2019
Completion date
August 21, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leptomeningeal disease, leptomeningeal metastases